Real-World Clinical Effectiveness of Liraglutide 3.0 mg for Weight Management in Canada.

ABSTRACT:

Objective

Real-world clinical effectiveness of liraglutide 3.0 mg, in combination with diet and exercise, was investigated 4 and 6 months post initiation. Changes in absolute and percent body weight were examined from baseline.

Methods

A cohort of liraglutide 3.0 mg initiators in 2015 and 2016 was identified from six Canadian weight-management clinics. Post initiation values at 4 and 6 months were compared with baseline values using a paired t test.

Results

The full cohort consisted of 311 participants, with 210 in the ≥ 4-month persistence group and 167 in the ≥ 6-month persistence group. Average baseline BMI was 40.7 kg/m² , and weight was 114.8 kg. There was a significant change in body weight 6 and 4 months after initiation of treatment in persistent su

SUBMITTER: Wharton S 

PROVIDER: S-EPMC6593982 | biostudies-literature | 2019 Jun

REPOSITORIES: biostudies-literature